For example, an alanine substitution at residue 198 greatly reduced Mcl-1′s anti-CIS activities, while a similar substitution at residue 201 or a deletion of Mcl-1′s three BH domains (Δ208–350) did not [10]. Here, MCL1 is linked to in situ carcinoma.